Quantamental Technologies’s Corcept Therapeutics CORT Stock Holding History

Quantamental Technologies’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,906	Closed	-$236K	–	527
2022 Q2	$236K	Buy	+9,906	New	+$216K	0.11%	311
2022 Q1	–	Sell	-11,026	Closed	-$218K	–	404
2021 Q4	$218K	Buy	+11,026	New	+$224K	0.11%	316
2020 Q4	–	Sell	-16,851	Closed	-$293K	–	138
2020 Q3	$293K	Buy	+16,851	New	+$269K	0.22%	154
2019 Q4	–	Sell	-12,160	Closed	-$172K	–	602
2019 Q3	$172K	Buy	12,160 +7,445	+158%	+$91.5K	0.06%	549
2019 Q2	$53K	Sell	4,715 -11,232	-70%	-$125K	0.02%	871
2019 Q1	$187K	Buy	15,947 +14,977	+1,544%	+$186K	0.09%	399
2018 Q4	$13K	Buy	+970	New	+$12.8K	0.01%	1096

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantamental Technologies's CORT Position: Q3 2022 in Review

Quantamental Technologies sold out of Corcept Therapeutics (CORT) in Q3 2022, closing a stake of 9,906 shares — an estimated $236K sold.

Quantamental Technologies first reported a position in CORT in Q4 2018 and held it in 7 quarters. The position peaked at $293K in Q3 2020. 238 funds tracked by Wall St. Rank hold CORT as of Q3 2022.

Quantamental Technologies reported no remaining Corcept Therapeutics position as of Q3 2022 after selling out during the quarter.
Quantamental Technologies sold 9,906 Corcept Therapeutics shares in Q3 2022, an estimated $236K.
Quantamental Technologies first reported a position in Corcept Therapeutics in Q4 2018 and held it in 7 quarters.
Quantamental Technologies's Corcept Therapeutics position peaked at $293K in Q3 2020.
238 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.